The Sleeping Giants of Vaccine Production Awaken

Oral vaccines Just-in-time delivery is advantageous for production and distribution facilities of all sizes, including the tiny ones known as living cells. For example, living cells can be used to generate mRNA and encapsulate it in virus-like particles. Thus packaged, the mRNA may be shipped to other cells, including the body’s cells, which accept delivery…

Read More

Esperovax Awarded BARDA Contract for Oral COVID-19 mRNA Vaccine

Esperovax, the leader in Egress RD™ Oral Biologics has been awarded $607,000 in funding from the (Biomedical Advanced Research and Development Authority (BARDA)), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, to further studies into the feasibility of oral vaccine production and…

Read More

Vaccine Venture

Biotech entrepreneur Roger Newton is back in the game-and working on a vaccine for Covid-19. by Ken Garber In April’s article “The Vindication of Roger Newton,” we quoted a colleague as saying that Newton, whose credits include the blockbuster drug Lipitor, had retired to northern Michigan. After the article came out, Newton got in touch…

Read More